Skip to search formSkip to main contentSkip to account menu

Disopyramide Phosphate

Known as: alpha-(2-(Diisopropylamino)ethyl)-alpha-phenyl-2-pyridineacetamide Phosphate(1:1), Disopyramide Phosphate (1:1), Disopyramide Phosphate [Chemical/Ingredient] 
A class Ia antiarrhythmic agent with cardiac depressant properties. Disopyramide phosphate exerts its actions by blocking both sodium and potassium… 
National Institutes of Health

Related topics

Related topics

15 relations
Anti-Arrhythmia AgentsAtrial FibrillationAtrial FlutterAtrial Premature Complexes

Narrower (3)

NorpacePalpitinRythmodan

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1983
1983
Hypoglycemia in Patients Receiving Disopyramide Phosphate
Postmarketing drug surveillance revealed the occurrence of hypoglycemia associated with the use of disopyramide phosphate… 
1983
1983
The Direct Electrophysiologic Effects of Disopyramide Phosphate in the Transplanted Human Heart
To evaluate the direct electrophysiologic effects of i.v. disopyramide phosphate and to differentiate these effects from its… 
1982
1982
Electrophysiologic Effects of Disopyramide Phosphate in Patients with Wolff‐Parkinson‐White Syndrome
We evaluated the electrophysiologic effects of disopyramide phosphate in 12 patients with the Wolff-Parkinson-White syndrome… 
1980
1980
Cardiac depression by intravenous disopyramide in patients with left ventricular dysfunction.
1980
1980
Response of atrial flutter to overdrive atrial pacing and intravenous disopyramide phosphate, singly and in combination.
Ten patients who suffered spontaneous paroxysms of atrial flutter were investigated by electrophysiological techniques. Two had… 
1979
1979
Cardiogenic shock and disopyramide phosphate.
DISOPYRAMIDE phosphate (Norpace) is a recently available antiarrhythmic drug. Although it has electrophysiologic properties… 
Highly Cited
1977
Highly Cited
1977
The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
Disopyramide phosphate was administered intravenously to 57 patients with 60 episodes of arrhythmia (21 supraventricular and 39… 
1977
1977
Quality of the ideal antiarrhythmic drug.
1974
1974
Comparative binding of disopyramide phosphate and quinidine sulfate to human plasma proteins.
Abstract Disopyramide phosphate and quinidine sulfate are pharmacologically related, but chemically unrelated, antiarrhythmic… 
1972
1972
Species differences in the biotransformation of a new antiarrhythmic agent: disopyramide phosphate.
Abstract The biotransformation of disopyramide phosphate [4-diisopropylamino-2-phenyl-2-(2-pyridyl)butyramide phosphate] was… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)